Literature DB >> 9393737

Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus.

E A Komarova1, C R Zelnick, D Chin, M Zeremski, A S Gleiberman, S S Bacus, A V Gudkov.   

Abstract

DNA damage leads to the stabilization of p53 protein and its translocation to the nucleus, resulting in activation or suppression of p53-responsive genes. However, a significant proportion of cell nuclei remain negative for p53 and p53-inducible cyclin-dependent kinase inhibitor p21waf1 after a single dose of gamma-irradiation. Quantitation of DNA content in p53-positive and -negative nuclei 4-6 h after 10 Gy of gamma-irradiation of human breast carcinoma MCF7 cells, fibrosarcoma HT1080 cells, and diploid skin fibroblasts showed that p53 and p21waf1 nuclear accumulation occurs predominantly in the G1 phase and at the beginning of the S phase of the cell cycle. The majority of the nuclei in late S phase and in G2-M phase remained p53- and p21waf1-negative. This suggests that there is a cell cycle window during which p53 can accumulate in the nucleus and activate expression of p21waf1. To determine whether cell cycle-dependent distribution of p53 is caused by cytoplasmic modifications of p53 protein or by properties of the nucleus, p53 localization was analyzed in multinucleated cells obtained by polyethylene glycol-mediated cell fusion. Dramatic differences in p53 accumulation were found among the nuclei in individual multinucleated cells. Distribution of p53-positive and -negative nuclei among the phases of the cell cycle was similar to that observed in a regular cell population. These results suggest that the observed differences in p53 accumulation in the nuclei of irradiated cells are determined by cell cycle-dependent nuclear functions. In contrast to p53, p21waf1 was equally distributed among the nuclei of multinucleated cells regardless of the stage of the cell cycle, indicating that the observed phenomenon is specific for p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393737

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.

Authors:  Jagat C Borah; Shiraz Mujtaba; Ioannis Karakikes; Lei Zeng; Michaela Muller; Jigneshkumar Patel; Natasha Moshkina; Keita Morohashi; Weijia Zhang; Guillermo Gerona-Navarro; Roger J Hajjar; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2011-04-22

4.  Hdm2- and proteasome-dependent turnover limits p21 accumulation during S phase.

Authors:  Daniel Ciznadija; Xin-Hua Zhu; Andrew Koff
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

5.  Stabilization and activation of p53 are regulated independently by different phosphorylation events.

Authors:  M V Chernov; C V Ramana; V V Adler; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 6.  p53: twenty five years understanding the mechanism of genome protection.

Authors:  M Gomez-Lazaro; F J Fernandez-Gomez; J Jordán
Journal:  J Physiol Biochem       Date:  2004-12       Impact factor: 4.158

7.  The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation.

Authors:  Debolina Ray; Keith R Murphy; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

8.  Hsf1 is required for the nuclear translocation of p53 tumor suppressor.

Authors:  Qiang Li; Rebecca A Feldman; Vijayababu M Radhakrishnan; Steven Carey; Jesse D Martinez
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 9.  Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy.

Authors:  Nikolina Vlatković; Mark T Boyd; Carlos P Rubbi
Journal:  Cell Mol Life Sci       Date:  2013-05-18       Impact factor: 9.261

10.  p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation.

Authors:  J Xu; G F Morris
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.